Rua Bioscience Limited - IPO and listing on the NZX Main Board
Photo: Rua Bioscience Co-founders Manu Caddie (L) and Panapa Ehau (R), with Rua CEO, Rob Mitchell at the company's listing event today at Uepohatu marae in Ruatorea
Lowndes Jordan is pleased to have advised Rua Bioscience Limited on its successful IPO and listing on the NZX Main Board (link). The IPO was supported by the founders and existing shareholders of Rua, with all $20 million raised from the IPO going towards funding its next stages of growth, with the aim of Rua becoming a leading producer in cannabinoid derived medicines. Rua's listing on the NZX also marked the first IPO in New Zealand for 2020.
Congratulations to the team at Rua.
Michael Busch led the corporate team at Lowndes Jordan assisted by senior associate, Joshua Woo, and associates, Liam Closey and Tamara McConnell.